The differential axonal degradation of Ret accounts for cell-type-specific function of glial cell line-derived neurotrophic factor as a retrograde survival factor.
Glial cell line-derived neurotrophic factor (GDNF) is a neuronal growth factor critical for the development and maintenance of central and peripheral neurons. GDNF is expressed in targets of innervation and provides support to several populations of large, projection neurons. To determine whether GDNF promotes retrograde survival over long axonal distances to cell bodies, we used a compartmentalized culture system. GDNF supported only modest and transient survival of postnatal sympathetic neurons when applied to their distal axons, in contrast to dorsal root ganglion (DRG) sensory neurons in which GDNF promoted survival equally well from either distal axons or cell bodies. Ret, the receptor tyrosine kinase for GDNF, underwent rapid proteasomal degradation in the axons of sympathetic neurons. Interestingly, the level of activated Ret in DRG neurons was sustained in the axons and also appeared in the cell bodies, suggesting that Ret was not degraded in sensory axons and was retrogradely transported. Pharmacologic inhibition of proteasomes only in the distal axons of sympathetic neurons caused an accumulation of activated Ret in both the axons and cell bodies during GDNF stimulation. Furthermore, exposure of the distal axons of sympathetic neurons to both GDNF and proteasome inhibitors, but neither one alone, promoted robust survival, identical to GDNF applied directly to the cell bodies. This differential responsiveness of sympathetic and sensory neurons to target-derived GDNF was attributable to the differential expression and degradation of the Ret9 and Ret51 isoforms. Therefore, the local degradation of Ret in axons dictates whether GDNF family ligands act as retrograde survival factors.
Tsui
Cynthia C
CC
Department of Internal Medicine-Nephrology Division, School of Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
Pierchala
Brian A
BA
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D001693:Biological Transport, Active; D018929:Cell Culture Techniques; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D005727:Ganglia, Spinal / Q000187:drug effects / Q000502:physiology*; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D046988:Proteasome Endopeptidase Complex / Q000502:physiology; D061988:Proteasome Inhibitors; D020033:Protein Isoforms / Q000378:metabolism; D051096:Proto-Oncogene Proteins c-ret / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000502:physiology; D017783:Superior Cervical Ganglion / Q000187:drug effects / Q000502:physiology*; D013997:Time Factors
D051100:Glial Cell Line-Derived Neurotrophic Factor; D061988:Proteasome Inhibitors; D020033:Protein Isoforms; D051096:Proto-Oncogene Proteins c-ret; C494999:Ret protein, mouse; C495001:Ret protein, rat; D046988:Proteasome Endopeptidase Complex
Nature. 1996 Jul 4;382(6586):76-9
8657308
Nature. 1996 Jun 27;381(6585):789-93
8657282
J Neurosci. 2000 Jul 1;20(13):5001-11
10864958
Science. 1987 Sep 4;237(4819):1154-62
3306916
Neuron. 1997 Oct;19(4):849-61
9354331
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10657-61
8855235
Neuron. 2006 Apr 6;50(1):35-47
16600854
J Biol Chem. 2002 Sep 13;277(37):34618-25
12091387
J Neurosci. 1999 Nov 1;19(21):9322-31
10531437
Neuron. 2002 Jan 17;33(2):261-73
11804573
Mol Cell Neurosci. 2000 Feb;15(2):199-214
10673327
Neuron. 1998 Jul;21(1):53-62
9697851
Neuron. 1995 Dec;15(6):1465-73
8845169
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6238-43
9177201
Neuron. 1998 Feb;20(2):245-53
9491986
Cell. 2004 Jul 23;118(2):243-55
15260993
J Neurosci. 1999 Oct 1;19(19):8207-18
10493722
Nature. 1995 Jan 26;373(6512):341-4
7830768
J Cell Biol. 1993 Dec;123(5):1207-22
7503996
J Cell Biol. 1995 Jul;130(1):137-48
7790368
J Biol Chem. 1999 Jul 23;274(30):20885-94
10409632
Neuron. 1995 Oct;15(4):821-8
7576631
Development. 2004 Nov;131(21):5503-13
15469971
Cell. 1996 Jun 28;85(7):1113-24
8674117
Nature. 1996 Jul 4;382(6586):80-3
8657309
J Biol Chem. 2005 Apr 8;280(14):13442-9
15677445
Neuron. 2002 Jul 18;35(2):267-82
12160745
Neuron. 2005 Mar 3;45(5):701-13
15748846
Neuron. 1998 Dec;21(6):1291-302
9883723
Mol Cell Neurosci. 2004 Oct;27(2):132-9
15485769
Development. 2000 Nov;127(22):4877-89
11044402
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9771-5
7568215
Science. 1993 May 21;260(5111):1130-2
8493557
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9092-6
7568079
Nature. 1996 Jul 4;382(6586):73-6
8657307
Nature. 1995 Jan 26;373(6512):344-6
7830769
FEBS Lett. 1999 Dec 10;463(1-2):63-6
10601639
Cell. 2003 Jun 27;113(7):867-79
12837245
Mech Dev. 2005 Jan;122(1):27-41
15582775
Science. 1994 Nov 11;266(5187):1062-4
7973664
Nature. 1996 Dec 5;384(6608):467-70
8945474
J Neurosci. 2000 Jul 1;20(13):4992-5000
10864957
Neuron. 2007 Jun 7;54(5):739-54
17553423
J Neurosci. 2006 Mar 8;26(10):2777-87
16525057
Cell Tissue Res. 1996 Nov;286(2):209-17
8854889
Science. 2000 Feb 25;287(5457):1489-93
10688798
J Neurosci. 2006 Mar 15;26(11):2981-90
16540576
Nature. 1996 Jul 4;382(6586):70-3
8657306
Neuron. 2002 Aug 29;35(5):893-905
12372284